Development and Validation of RP-HPLC Method for the Simultaneous Estimation of Tenofovir Alafenamide Fumarate and Emtricitabine in Bulk and Tablet Dosage Form
New Analytical method was developed for the estimation of Emtricitabine and Tenofovir Alafenamide Fumarate in drug product by liquid chromatography. The chromatographic separation was achieved on Cosmosil C18 column (250mm×4.6ID, 5µm) at ambient temperature. The separation achieved employing a mobile phase consists of Methanol:water(80:20v/v). The flow rate was 0.8ml/ minute and ultra violet detector at 252nm. The average retention time for Emtricitabine and Tenofovir Alafenamide Fumarate found to be 4.277min and 5.293min. The proposed method was validated for selectivity, precision, linearity and accuracy. All validation parameters were within the acceptable range. The assay methods were found to be linear from 10-50µg/ml for Emtricitabine and 15-75µg/ml for Tenofovir Alafenamide Fumarate.
Keywords: Emtricitabine and Tenofovir Alafenamide Fumarate, HPLC, Methanol and validation.
2. ICH, Q2B, Validation of Analytical Procedures: Methodology, International Conference on Harmonization, Geneva, 1996.
3. ICH, Q2 (R1). Validation of analytical procedures: text and methodology, International Conference on Harmonization, Geneva, 2005.
4. Akram N.M.D., Umamahesh M, A New validation RP HPLC method for the determine of Emtricitabine and Tenofovir AF in bulk and pharmaceutical dosage form. Journal of chemical and pharmaceutical science. 2017; 10(4).
5. Badgujar BP, Mahajan MP, Sawant SD, Development and validation of RP-HPLC method for the simultaneouse estimation of Tenofovir Alafenamide and Emtricitabine in bulk and tablet dosage form, International Journal of Chem Tech Research,2017; 10(5):731-739
6. Mastanamma K, Venkata Reddy D, Saidulu P, Varalakhim M, Development and validation of Stability Indicating RP-HPLC method Simultaneous Estimation of Emtricitabine Tenofovir Alafenamide bulk and their combined dosage form . Journal of chemical and Pharmaceutical Research 2017; 9(9):70-80
7. Benzil Dudekula, Dr. Ravichandran, Dr. C.Ramachandraih, Development and validation of RP-HPLC method for the simultaneous estimation of emtricitabine and tenofovir alafenamide in bulk and tablet dosage from ,European journal of biomedical and pharmaceutical science,2017; 4(10):663-668
8. Indian Pharmacopoeia, Govt. of India, Published by Indian pharmacopoeia commission, Gaziabad, 2014; vol I and II: 190, 2157, 1237.
9. United States Pharmacopoeia 34, NF29, United State pharmacopeial Convention, Rockville, Meryland, U.S.A., 2011; vol I:2114,3391.
10. The Merk Index, published by Merk and Co. Inc., Whitehouse station, N.J., U.S.A.,1989; 248, 905.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).